We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
-12.26%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$19B
AUM Growth
-$3.13B
Cap. Flow
-$232M
Cap. Flow %
-1.22%
Top 10 Hldgs %
15.64%
Holding
2,990
New
179
Increased
1,185
Reduced
1,102
Closed
425

Sector Composition

Rank Sector Weight
1 Technology 8.84%
2 Financials 7.59%
3 Healthcare 7.23%
4 Consumer Discretionary 4.71%
5 Industrials 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IZEA icon
2526
IZEA Worldwide
IZEA
$62.5M
$11K ﹤0.01%
2,759
PTN
2527
Palatin Technologies
PTN
$13.3M
$11K ﹤0.01%
13
-1
-7% -$1.04K
SLV icon
2528
CALL
iShares Silver Trust
SLV
$31.5B
$11K ﹤0.01%
40,500
FGP
2529
DELISTED
Ferrellgas Partners, L.P.
FGP
$10K ﹤0.01%
18,152
+2,087
+13% +$2.92K
XLF icon
2530
CALL
State Street Financial Select Sector SPDR ETF
XLF
$59.1B
$9K ﹤0.01%
10,700
-5,300
-33% -$138K
SN
2531
DELISTED
Sanchez Energy Corporation
SN
$9K ﹤0.01%
33,818
+22,900
+210% +$29.3K
AST
2532
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$9K ﹤0.01%
14,630
-3,308
-18% -$3.43K
HOV icon
2533
Hovnanian Enterprises
HOV
$814M
$8K ﹤0.01%
485
+4
+0.8% +$127
NAK
2534
Northern Dynasty Minerals
NAK
$953M
$8K ﹤0.01%
14,399
-203,980
-93% -$122K
ATNM icon
2535
Actinium Pharmaceuticals
ATNM
$24.9M
$7K ﹤0.01%
573
CLDX icon
2536
Celldex Therapeutics
CLDX
$3.46B
$6K ﹤0.01%
1,942
-5
-0.3% -$25
F icon
2537
CALL
Ford
F
$55.7B
$6K ﹤0.01%
52,500
+11,500
+28% +$102K
CATX icon
2538
Perspective Therapeutics
CATX
$364M
$5K ﹤0.01%
1,750
NWL icon
2539
CALL
Newell Brands
NWL
$2.59B
$5K ﹤0.01%
15,300
+4,900
+47% +$97.5K
ADT icon
2540
CALL
ADT
ADT
$5.5B
$4K ﹤0.01%
28,100
+300
+1% +$2.26K
ZTS icon
2541
CALL
Zoetis
ZTS
$31.1B
$4K ﹤0.01%
27,400
-700
-2% -$63K
HURA
2542
TuHURA Biosciences
HURA
$146M
$4K ﹤0.01%
1
ADXS
2543
DELISTED
Advaxis Inc
ADXS
$4K ﹤0.01%
1,325
KMI icon
2544
CALL
Kinder Morgan
KMI
$70.1B
$3K ﹤0.01%
+12,700
New +$215K
CSCO icon
2545
CALL
Cisco
CSCO
$476B
$2K ﹤0.01%
11,400
-4,500
-28% -$206K
T icon
2546
CALL
AT&T
T
$167B
$2K ﹤0.01%
27,142
-530
-2% -$12.3K
BPTH
2547
DELISTED
Bio-Path Holdings Inc
BPTH
$2K ﹤0.01%
36
-1
-3% -$172
BAC icon
2548
CALL
Bank of America
BAC
$448B
$1K ﹤0.01%
+10,100
New +$274K
JPM icon
2549
CALL
JPMorgan Chase
JPM
$963B
$1K ﹤0.01%
+10,100
New +$1.08M
SWBI icon
2550
CALL
Smith & Wesson
SWBI
$637M
$1K ﹤0.01%
27,191
-1,561
-5% -$16.2K

Similar funds

Raymond James Financial Services Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James Financial Services Advisors held 2,990 positions worth $19B, down 14% from $22.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James Financial Services Advisors's Q4 2018 filing shows 179 new, 1,185 increased, 1,102 reduced and 425 closed positions. Its largest new stake was Linde: 66,232 shares worth $10.5M. The largest sale was iShares Core S&P Small-Cap ETF, an estimated $244M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, down from 9.2% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q4 2018 buy was Linde: 66,232 shares worth $10.5M.
  • Raymond James Financial Services Advisors added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $66.8M increase.
  • Raymond James Financial Services Advisors's biggest Q4 2018 reduction was Oracle, cutting an estimated $51.3M.
  • Raymond James Financial Services Advisors fully exited iShares Core S&P Small-Cap ETF in Q4 2018, selling an estimated $244M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 16% of its $19B portfolio in Q4 2018.
  • Raymond James Financial Services Advisors opened 179 new positions and closed 425 in Q4 2018.
  • Raymond James Financial Services Advisors's portfolio value fell 14% quarter-over-quarter to $19B.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.